Minerva Neurosciences (NERV) Misses Q1 EPS by 4c

Minerva Neurosciences (NASDAQ: NERV) reported Q1 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• UBS says bull market has further to run
• Envoy Medical (COCH) PT Lowered to $2 at H.C. Wainwright
• Walmart (WMT) PT Lowered to $130 at UBS as Investment Narrative's Competing Dynamics